Zhu, Q., Zhao, J., Shen, P., Zhang, M., Wang, Q. (2025). Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps299